We are live on ! Find out more
CIS

Capital International Sarl Portfolio holdings

AUM $6.11B
1-Year Est. Return 32.29%
This Fund
S&P 500
This Quarter Est. Return
+14.26%
1 Year Est. Return
+32.29%
3 Year Est. Return
+120.6%
5 Year Est. Return
+165.23%
10 Year Est. Return
+684.77%
AUM
$2.67B
AUM Growth
+$484M
Cap. Flow
+$193M
Cap. Flow %
7.23%
Top 10 Hldgs %
28.33%
Holding
229
New
8
Increased
140
Reduced
50
Closed
7

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$18.6M
2
META icon
Meta Platforms (Facebook)
META
+$13.3M
3
AVGO icon
Broadcom
AVGO
+$9.41M
4
TSLA icon
Tesla
TSLA
+$7.57M
5
CRM icon
Salesforce
CRM
+$7.36M

Top Sells

Rank Stock Value
1
SGEN
Seagen Inc. Common Stock
SGEN
+$8.99M
2
EW icon
Edwards Lifesciences
EW
+$6.3M
3
SRE icon
Sempra
SRE
+$4.5M
4
CTVA icon
Corteva
CTVA
+$3.85M
5
HES
Hess
HES
+$3.02M

Sector Composition

Rank Sector Weight
1 Technology 26.32%
2 Healthcare 16.49%
3 Consumer Discretionary 13.29%
4 Financials 10.76%
5 Industrials 10.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RVTY icon
201
Revvity
RVTY
$13B
$1.3M 0.05%
11,876
+4,582
+63% +$442K
TXN icon
202
Texas Instruments
TXN
$261B
$1.3M 0.05%
7,600
-650
-8% -$101K
SQM icon
203
Sociedad Química y Minera de Chile
SQM
$20.6B
$1.25M 0.05%
20,824
LECO icon
204
Lincoln Electric
LECO
$15.4B
$1.13M 0.04%
5,201
JKHY icon
205
Jack Henry & Associates
JKHY
$11B
$1.12M 0.04%
6,869
PNC icon
206
PNC Financial Services
PNC
$101B
$1.11M 0.04%
7,157
SAND
207
DELISTED
Sandstorm Gold
SAND
$1.1M 0.04%
219,325
NSC icon
208
Norfolk Southern
NSC
$75B
$976K 0.04%
4,127
CPAY icon
209
Corpay
CPAY
$26.6B
$912K 0.03%
3,226
+583
+22% +$145K
ZTO icon
210
ZTO Express
ZTO
$17.7B
$823K 0.03%
38,679
+15,079
+64% +$342K
GLNG icon
211
Golar LNG
GLNG
$5.13B
$637K 0.02%
27,717
-27,321
-50% -$613K
BUD icon
212
AB InBev
BUD
$160B
$572K 0.02%
8,851
MOD icon
213
Modine Manufacturing
MOD
$10.8B
$542K 0.02%
9,082
-7,529
-45% -$368K
ZLAB icon
214
Zai Lab
ZLAB
$2.81B
$474K 0.02%
17,328
LI icon
215
Li Auto
LI
$12.3B
$453K 0.02%
12,112
NBIS
216
Nebius Group N.V.
NBIS
$49.1B
$402K 0.02%
26,238
-92,786
-78% -$1.42M
MRNA icon
217
Moderna
MRNA
$24.3B
$375K 0.01%
3,767
-8,605
-70% -$724K
G icon
218
Genpact
G
$5.67B
$372K 0.01%
10,726
LRCX icon
219
Lam Research
LRCX
$395B
$258K 0.01%
3,300
MOH icon
220
Molina Healthcare
MOH
$10.3B
$236K 0.01%
653
SPOT icon
221
Spotify
SPOT
$106B
$221K 0.01%
+1,176
New +$205K
AR icon
222
Antero Resources
AR
$11.4B
-45,850
Closed -$1.16M
EOG icon
223
EOG Resources
EOG
$74.3B
-11,966
Closed -$1.52M
LOGI icon
224
Logitech
LOGI
$15B
-4,570
Closed -$315K
TECH icon
225
Bio-Techne
TECH
$11.3B
-5,776
Closed -$393K

Similar funds

Capital International Sarl's Q4 2023 Portfolio in Review

As of Q4 2023, Capital International Sarl held 229 positions worth $2.67B, up 22% from $2.19B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Capital International Sarl deployed $193M of net new capital in Q4 2023, opening 8 new positions and adding to 140 existing holdings. Its largest new stake was Brookfield: 172,452 shares worth $4.61M.

By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 24% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was Edwards Lifesciences, an estimated $6.3M trimmed.

  • Capital International Sarl's largest Q4 2023 buy was Brookfield: 172,452 shares worth $4.61M.
  • Capital International Sarl added most to Microsoft in Q4 2023, an estimated $18.6M increase.
  • Capital International Sarl's biggest Q4 2023 reduction was Edwards Lifesciences, cutting an estimated $6.3M.
  • Capital International Sarl fully exited Seagen Inc. Common Stock in Q4 2023, selling an estimated $8.99M.
  • Capital International Sarl's ten largest holdings make up 28% of its $2.67B portfolio in Q4 2023.
  • Capital International Sarl opened 8 new positions and closed 7 in Q4 2023.
  • Capital International Sarl's portfolio value rose 22% quarter-over-quarter to $2.67B.

Based on Capital International Sarl's 13F filing for Q4 2023, filed 13 Feb 2024.